You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

NONOXYNOL-9 - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for nonoxynol-9 and what is the scope of freedom to operate?

Nonoxynol-9 is the generic ingredient in two branded drugs marketed by Personal Prods and Mayer Labs Inc, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for nonoxynol-9.

Summary for NONOXYNOL-9
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 1
Raw Ingredient (Bulk) Api Vendors: 49
Clinical Trials: 9
Patent Applications: 6,007
What excipients (inactive ingredients) are in NONOXYNOL-9?NONOXYNOL-9 excipients list
DailyMed Link:NONOXYNOL-9 at DailyMed
Recent Clinical Trials for NONOXYNOL-9

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
BayerPhase 1
CONRADPhase 2
Evofem Inc.Phase 3

See all NONOXYNOL-9 clinical trials

US Patents and Regulatory Information for NONOXYNOL-9

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Personal Prods DELFEN nonoxynol-9 AEROSOL;VAGINAL 014349-002 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Mayer Labs Inc TODAY nonoxynol-9 SPONGE;VAGINAL 018683-001 Apr 1, 1983 DISCN Yes No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

NONOXYNOL-9 Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Nonoxynol-9 in the Spermicides Market

Market Scenario

The global spermicides market, which is a significant segment of the contraceptive industry, is experiencing notable growth. As of 2023, the market was valued at US$ 8.92 billion and is projected to reach US$ 15.12 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 6.04% during the forecast period of 2024-2032[1].

Dominance of Nonoxynol-9

Nonoxynol-9 is the leading active ingredient in the spermicides market, accounting for 56.3% of the revenue share. Its efficacy in rapidly immobilizing and killing sperm has established it as a trusted and reliable component in spermicidal products. The segment is expected to grow at a CAGR of 6.48% during the forecast period, driven by continuous research and development efforts aimed at improving its efficacy while minimizing potential side effects such as irritation[1].

Regional Analysis

Geographically, the Asia Pacific region leads the market, holding about 48% of the global share, driven by consumer awareness and product availability. Europe follows, accounting for roughly 22% of the market, with countries like the UK and Germany being key contributors. In North America, particularly in the U.S., there has been a 20% rise in spermicides sales over the past three years, fueled by the availability of diverse products and easy access through both offline and online channels[1].

Market Drivers

Rising Demand for Non-Hormonal Contraceptives

The increasing demand for non-hormonal contraceptives is a significant driver for the spermicides market. Nonoxynol-9, being a non-hormonal option, benefits from this trend. The availability of nonoxynol-9 based products in various forms such as gels, creams, and films caters to different consumer preferences, expanding the market reach[1].

Consumer Awareness and Education

Educational initiatives have played a crucial role in increasing the usage of spermicides. For instance, targeted educational efforts have led to a 15% increase in usage in certain areas. This underscores the importance of continued educational campaigns in driving market growth[1].

Market Challenges

Health Concerns and Side Effects

Despite its dominance, nonoxynol-9 faces challenges related to health concerns. Long-term use of nonoxynol-9 has been associated with dose-dependent effects on vaginal microflora, including an increased risk of bacterial vaginosis and other microbial imbalances. These findings have led to a 10% decline in sales of products containing nonoxynol-9 due to consumer sensitivity to side effects[1][2].

Regulatory Impacts

Regulatory changes, particularly in the European Union, have resulted in a 5% reduction in available spermicide brands. This highlights the significant influence of policy on market dynamics and the need for manufacturers to comply with evolving regulatory standards[1].

Financial Trajectory

Revenue and Growth Projections

The nonoxynol-9 segment is expected to continue its growth trajectory, driven by research and development investments. Leading companies are allocating approximately 8% of their revenues towards R&D, focusing on creating new, more effective formulations. This investment is likely to sustain the segment's growth, despite current challenges[1].

Market Segmentation and Product Variety

The market's financial health is also bolstered by the variety of products available. Nonoxynol-9 based products are sold in various forms, which not only expands the consumer base but also increases revenue streams. The ease of access to these products, both in physical stores and online platforms, has significantly contributed to the segment's financial performance[1].

Emerging Trends

Eco-Friendly and Organic Products

There is a growing trend towards environmentally friendly and organic spermicides, which currently represent about 10% of the market. This segment is expected to grow rapidly as consumers become more health-conscious and environmentally aware. This shift presents an opportunity for manufacturers to diversify their product lines and capture a growing market share[1].

Consumer Satisfaction and Market Accessibility

Consumer Approval

Despite the challenges, consumer satisfaction with spermicides remains high, with a 70% approval rating. This indicates a solid foundation for future growth, provided that manufacturers address the existing concerns and adapt to evolving consumer preferences[1].

Accessibility Issues

However, accessibility remains a challenge, particularly in developing countries where over 50% of health centers and pharmacies have inconsistent stock of spermicides. Price sensitivity is also a concern, with a recent 5% price increase affecting demand in certain markets. Addressing these issues will be crucial for sustained market growth[1].

Future Outlook

The future of the nonoxynol-9 market looks promising, despite the current challenges. Continued investment in innovation, adaptation to consumer preferences, and educational initiatives are expected to drive growth. Here are some key points to consider:

  • Innovation and R&D: Ongoing research aimed at improving the efficacy and safety of nonoxynol-9 will be critical.
  • Regulatory Compliance: Manufacturers must navigate and comply with evolving regulatory standards.
  • Consumer Education: Continued educational efforts will help increase awareness and usage.
  • Market Adaptation: Adapting to trends such as the demand for eco-friendly and organic products will be essential.

Key Takeaways

  • The nonoxynol-9 segment dominates the spermicides market with a 56.3% revenue share.
  • The segment is expected to grow at a CAGR of 6.48% during the forecast period.
  • Health concerns and regulatory impacts are significant challenges.
  • Consumer awareness and education are key drivers of market growth.
  • Emerging trends include a shift towards eco-friendly and organic products.
  • Accessibility and price sensitivity remain critical issues to address.

FAQs

1. What is the current market size of the global spermicides market? The global spermicides market was valued at US$ 8.92 billion in 2023[1].

2. What is the projected growth rate of the nonoxynol-9 segment in the spermicides market? The nonoxynol-9 segment is projected to grow at a CAGR of 6.48% during the forecast period of 2024-2032[1].

3. What are the main challenges facing the nonoxynol-9 market? The main challenges include health concerns related to side effects, regulatory impacts, and accessibility issues in developing countries[1][2].

4. How is consumer awareness impacting the spermicides market? Consumer awareness and educational initiatives have led to a 15% increase in usage in targeted areas, highlighting the importance of continued educational efforts[1].

5. What emerging trends are influencing the spermicides market? There is a growing trend towards environmentally friendly and organic spermicides, which currently represent about 10% of the market and are expected to grow rapidly[1].

Sources

  1. Astute Analytica: Spermicides Market Size, Share, Growth | Report [2024-2032][1]
  2. PubMed: Effects of long-term use of nonoxynol-9 on vaginal flora[2]
  3. NCBI: The Market for New Contraceptives: Translating Unmet Need[3]
  4. Guttmacher Institute: Condoms, Contraceptives and Nonoxynol-9: Complex Issues[4]
  5. PLOS ONE: Spermicidal and Contraceptive Potential of Desgalactotigonin[5]

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.